Hexagon Nutrition FY26 PAT surges 56% to ₹379 million; AGM on Sep 22

scanx
Reviewed by
Ashish TScanX News Team
Key Highlights
  • Consolidated PAT surged 56% YoY to ₹379.37 million in FY26, outpacing 17.8% revenue growth
  • EBITDA margin expanded by 150 bps to 13.8%, reflecting improved operational efficiency
  • Branded nutrition segment crossed ₹1,000 million mark with 23.74% YoY growth
  • Company scheduled 33rd AGM for September 22, 2026, recommending ₹0.30 per share final dividend
  • Web-links for Integrated Annual Report distributed to members without registered emails
powered bylight_fuzz_icon
49742544

*this image is generated using AI for illustrative purposes only.

Hexagon Nutrition has scheduled its 33rd Annual General Meeting for September 22, 2026, alongside reporting its strongest-ever financial performance for FY2025-26, with consolidated profit after tax rising 56% year-on-year to ₹379.37 million.

The company has also intimated the distribution of web-links for its Integrated Annual Report to members without registered email addresses, ensuring access to the notice convening the AGM and the annual report for FY26.

FY26 Financial Highlights

The company's consolidated revenue from operations grew 17.8% year-on-year to ₹3,826.28 million in FY2025-26, compared to ₹3,249.29 million in FY2024-25. Profitability expanded well ahead of revenue, with EBITDA rising 32.0% to ₹529 million and EBITDA margin widening to 13.8% from 12.3% in the prior year. PAT margin improved to 9.9% from 7.5%.

Metric FY2025-26 FY2024-25 Change
Revenue from Operations (₹ mn) 3,826.28 3,249.29 +17.8%
EBITDA (₹ mn) 529 401 +32.0%
EBITDA Margin (%) 13.8 12.3 +150 bps
Profit After Tax (₹ mn) 379.37 243.05 +56.1%
PAT Margin (%) 9.9 7.5 +240 bps
Basic EPS (₹) 3.43 1.75 +96.0%
Return on Equity (%) 17.8 10.8 +700 bps
Net Debt/Equity (times) 0.13 0.14

On a standalone basis, revenue from operations stood at ₹3,191.20 million versus ₹2,674.47 million in FY2024-25, with standalone PAT at ₹381.48 million compared to ₹269.69 million.

Segment Performance

The company operates across three segments. The branded nutrition (B2C) segment delivered year-on-year growth of 23.74%, crossing the ₹1,000 million mark. The premix formulations (B2B2C) segment grew 31% overall, with domestic premix up 44.06% and export premix up 24.87%. The ESG segment declined 16.51% due to delays in tender releases.

Segment Revenue (₹ mn) Share (%)
Branded Nutrition (B2C) 1,139.56 30
Premix Formulations (B2B2C) 2,026.48 53
ESG Segment 649.95 17

Export revenue contributed approximately 57% of total FY26 revenue, with the company exporting to 80+ countries across five continents.

IPO Listing and Corporate Developments

Hexagon Nutrition listed on the NSE and BSE on June 12, 2026, through a 100% Offer for Sale of 3,08,59,704 equity shares at an issue price of ₹45 per share, aggregating to ₹138.87 crore. The IPO was subscribed 53.68 times overall, with the QIB portion subscribed 19.77 times, NII 161.49 times, and retail 26.85 times. The listing price was ₹48.25 per share on NSE and ₹48.00 per share on BSE.

During the year, Hexagon Nutrition (Exports) Private Limited was amalgamated with the company pursuant to an NCLT order dated January 14, 2026, with an appointed date of April 1, 2025.

Dividend and AGM Agenda

The Board has recommended a final dividend of ₹0.30 per equity share of face value ₹1 each for FY2025-26, subject to shareholder approval at the AGM. The record date for dividend eligibility is September 15, 2026, and the dividend payment date is between September 23, 2026 and October 22, 2026.

The 33rd AGM will be held on Tuesday, September 22, 2026 at 11:30 am (IST) through video conferencing. Key resolutions include adoption of financial statements, re-appointment of Dr. Nikhil Arun Kelkar as Joint Managing Director, declaration of the final dividend, appointment of Raghunath Sawant as Executive Director, revision in remuneration of executive directors, and alteration of the Articles of Association.

AGM Detail Particulars
Date September 22, 2026
Time 11:30 am IST
Mode Video Conferencing / OAVM
Record Date September 15, 2026
Remote e-Voting Period September 19, 2026 (9:00 am) to September 21, 2026 (5:00 pm)

Members who have not registered their email addresses can access the Annual Report and AGM Notice via the web-link provided by the company. The exact path is Investors → Annual Report → Hexagon Nutrition Limited → Annual Report 2025-26 on the company website.

Key Financial Ratios

Ratio FY2025-26 FY2024-25
Current Ratio (times) 3.38 3.50
Return on Capital Employed (%) 20.9 17.1
Net Worth (₹ mn) 2,333 1,942
Debt Service Coverage Ratio 1.89 1.52

The company's R&D expenditure for FY26 stood at ₹18.35 million. Foreign exchange inflows were ₹1,498.79 million and outflows were ₹660.91 million during the year.

Historical Stock Returns for Hexagon Nutrition

1 Day5 Days1 Month6 Months1 Year5 Years
-1.94%-4.29%-7.32%+44.60%+44.60%+44.60%

How might the 16.51% decline in the ESG segment impact Hexagon Nutrition's overall growth trajectory once government tender delays are resolved?

Given that exports constitute 57% of revenue, what hedging strategies is the company employing to mitigate currency fluctuation risks in its top export markets?

Will the proposed revision in executive director remuneration align with performance metrics tied to the recent 56% PAT surge, and how will shareholders react?

Hexagon Nutrition faces ₹1.04 Cr customs duty demand and penalty

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights
  • Hexagon Nutrition faces a ₹1.04 crore customs demand from Chennai III commissioner
  • Order cites misclassification of CTH codes for DTA unit sales
  • Breakdown includes ₹81.7 lakh duty, ₹15 lakh fine, and ₹8 lakh penalty
  • Company plans to appeal, citing strong merits and no operational impact
  • HNEPL subsidiary was amalgamated with parent in January 2026
powered bylight_fuzz_icon
49819983

*this image is generated using AI for illustrative purposes only.

Hexagon Nutrition Limited received a customs duty demand and penalty aggregating to ₹1.04 crore from the Commissioner of Customs, Chennai III. The order, dated August 27, 2026, was issued against Hexagon Nutrition Exports Private Limited (HNEPL), a previously wholly owned subsidiary amalgamated with the parent company in January 2026.

The customs authority alleged misclassification of Combined Nomenclation (CTH) codes for products sold to Domestic Tariff Area (DTA) units. This classification error reportedly led to discrepancies in Basic Customs Duty and Social Welfare Surcharge payments.

Breakdown of Demand

The total financial impact outlined in the order includes specific components for duty, fines, and penalties. The company states that the immediate financial impact is limited to these amounts plus applicable interest.

Component Amount
Customs Duty ₹81.7 lakh
Fine ₹15 lakh
Penalty ₹8 lakh
Total Demand ₹1.04 crore

The order was received on Saturday, August 29, 2026. Hexagon Nutrition initiated an internal review and sought legal counsel advice before making the disclosure on September 1, 2026, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Legal Response

The company strongly disagrees with the findings of the order. Management believes it has a strong case on merits and is preparing to file an appeal before the relevant appellate authority within statutory timelines. Hexagon Nutrition expects a favorable outcome at the appellate level and asserts there is no material impact on its operational activities.

What the Numbers Show

The customs duty component constitutes approximately 78% of the total ₹1.04 crore demand, indicating that the core dispute revolves around tariff classification rather than punitive measures alone. The relatively smaller fine and penalty portions suggest the authority viewed the misclassification as a procedural contravention rather than willful evasion, though the final determination rests with the appellate authority.

Historical Stock Returns for Hexagon Nutrition

1 Day5 Days1 Month6 Months1 Year5 Years
-1.94%-4.29%-7.32%+44.60%+44.60%+44.60%

How might the outcome of this customs appeal influence Hexagon Nutrition's future supply chain compliance strategies and internal audit processes?

Could this dispute signal broader regulatory scrutiny on tariff classifications for other Indian nutraceutical exporters, potentially affecting sector-wide margins?

What is the estimated timeline for the appellate process, and how might prolonged litigation impact investor sentiment and stock volatility in the interim?

More News on Hexagon Nutrition

1 Year Returns:+44.60%